Evidence map›Paper›PMID 41804473›Full record

ArticleClinical case reports2026

Preserving Pulp Vitality With Full Pulpotomy Using Mineral Trioxide Aggregate in Permanent Molars Affected With Symptomatic Irreversible Pulpitis: A 12-24 Months Case Series.

Neelam D Chandwani, Anjali Gayke, Ranjana Deshmukh, Mohmed Isaqali Karobari

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Neelam D ChandwaniDepartment of Dentistry All India Institute of Medical Sciences Nagpur Maharashtra India.
Anjali GaykeDepartment of Dentistry All India Institute of Medical Sciences Nagpur Maharashtra India.
Ranjana DeshmukhDepartment of Dentistry All India Institute of Medical Sciences Nagpur Maharashtra India.
Mohmed Isaqali KarobariDepartment of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences Saveetha University Chennai Tamil Nadu India.ORCID https://orcid.org/0000-0002-0313-9695

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintaining and preserving the remaining pulp vitality is the latest minimally invasive and conservative treatment option. In-depth knowledge of pulp inflammation and its reparative process has enhanced the adaptation of full pulpotomy as a vital pulp therapy. The growing research in dental biomaterials over the last 30-50 years has led to increased interest in such therapy. In this series of three case presentations, the clinical and radiographic outcomes at 12 to 24 months following a mineral trioxide aggregate (MTA) full pulpotomy in permanent molars with symptoms of irreversible pulpitis were evaluated. After caries removal from the affected molars, amputation of the inflamed pulp to the canal orifice was performed under rubber dam isolation and magnification. Mineral Trioxide Aggregate was placed over the healthy radicular pulp after complete hemostasis, followed by placement of permanent restoration. The patients were recalled for clinical and radiographic follow-up at intervals of 12-24 months. Throughout the follow-up periods, all teeth demonstrated a successful outcome with a distinct healing pattern and a disappearance of signs and symptoms. Hence, MTA pulpotomy could be considered a practical treatment approach for teeth affected by irreversible pulpitis.

Indexed as

mineral trioxide aggregatepulpitispulpotomyvital pulp therapy

Identifiers

PMID41804473
PMCPMC12967645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.